Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > XPDT COMING SOON TO TLT

<< Previous

Bullboard Posts

Next >>

Post by Tarbabyon Feb 05, 2024 10:48am

275 Views

Post# 35862969

XPDT COMING SOON TO TLT

TLT have already done experiments with XPDTfor deep tumours. More is coming. For brain lung and other deep tumours.
This will be the most exciting new cancer treatment worldwide.
So simple but effective..and no chemo or super expensive immunotherapy drugs..
In fact this treatment does trigger an immune response according to posted studies.

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading